Vascugen is an induced pluripotent stem cell (iPSC) therapy company advancing its novel vasculogenic cell technology to develop and manufacture engineered vascular cells. Our vasculogenic cells have the potential to directly address ischemic disease conditions and to serve as a novel platform for delivery of therapeutic payloads in cardiovascular,solid tumor, and other indications. Vascugen’s research and development facility includes an integrated manufacturing facility for early-stage clinical manufacture of our products.

Biotechnology

Health Care

Vascugen

Vascugen's headquarters in Madison, WI, United States

Description

People (3)

David Mann

Kemi Adeyanju, PhD

Matthew George

Jobs